Tradestie Institutional Equity Comparison Engine

CRON vs AYTU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRON Overall Edge

CRON Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cronos Group Inc. Common Share (CRON) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while AYTU counters with relative strength in Valuation. Fundamentally, CRON trades at 13.3x Forward P/E with 6.1% operating margin (+74.6% YoY revenue) versus AYTU at 9.2x Forward P/E and -14.4% operating margin (+6.4% YoY). In options structure, CRON sits in CONSOLIDATION (20th %ile IV; Dealer Gamma Walls on Pro) against AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AYTU
CRON 13.3x vs AYTU 9.2x Fwd P/E
Growth & Margin Winner CRON
Op Margin 6.1% vs -14.4% ยท YoY +74.6% vs +6.4%
Momentum & Technical Winner CRON
1Y +31.6% vs -12.1% ยท 52W Pos 60% vs 5%
Options & Structure Winner CRON
CONSOLIDATION (20th %ile IV) vs UNCLASSIFIED (N/A IV)
CRON NASDAQ
Cronos Group Inc. Common Share
Medicinal Chemicals & Botanical Products
$3.26
-3.48% 1D
Market Cap $1.2B
1M Return +1.63%
1Y Return +31.55%
Forward P/E 13.3x
Unified AI Score
53.9 / 100 HOLD
Tech 46.0 Fund 51.0 Flow 58.0 Mom 50.0
AYTU NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap $19.6M
1M Return -11.27%
1Y Return -12.14%
Forward P/E 9.2x
Unified AI Score
48.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRON +31.55% AYTU -12.14% Spread: +43.69 pp (CRON Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRON Revenue AYTU Revenue CRON Op. Margin AYTU Op. Margin Margin Edge
FY2019 $20M $10M -645.5% -230.1% AYTU
FY2020 $50M $30M -469.6% -76.5% AYTU
FY2021 $60M $70M -452.2% -89.7% AYTU
FY2022 $90M $100M -128.4% -113.7% AYTU
FY2023 $90M $110M -97.2% -15.9% AYTU
FY2024 $120M $70M -65.1% -2.4% AYTU
FY2025 $150M $70M -11.9% -11.8% AYTU
FY2026 N/A $60M N/A -14.4% AYTU

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRON (7) vs AYTU (3)
Institutional Metric CRON AYTU Criterion Row Winner
Market Capitalization Scale $1.2B $19.6M Larger Scale CRON
Trailing P/E Ratio Valuation 21.3x 9.2x Lower Multiple AYTU
Forward P/E Ratio Valuation 13.3x 9.2x Lower Multiple AYTU
Revenue Growth (YoY) Growth +74.6% +6.4% Higher Growth CRON
Operating Margin (TTM) Profitability 6.1% -14.4% Higher Margin CRON
Net Profit Margin Profitability 28.0% -24.8% Higher Margin CRON
Return on Equity (ROE) Capital Efficiency 6.1% -52.5% Higher ROE CRON
52-Week Range Position Momentum 60% ($2โ€“$4) 5% ($2โ€“$3) Stronger Trend CRON
Beta / 30D Volatility Risk Regime 0.35ฮฒ ยท 40% Vol 0.65ฮฒ ยท 35% Vol Lower Realized Risk AYTU
Unified Institutional Score Composite Signal 53.9 / 100 (HOLD) 48.9 / 100 (HOLD) Higher Composite CRON

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRON vs AYTU Buy Guide
CRON CONSOLIDATION
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live CRON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AYTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AYTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRON nor AYTU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.